Belfast Health and Social Care Trust
🇬🇧United Kingdom
Clinical Trials
74
Active:31
Completed:21
Trial Phases
5 Phases
Phase 1:15
Phase 2:10
Phase 3:6
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (54 trials with phase data)• Click on a phase to view related trials
Not Applicable
22 (40.7%)Phase 1
15 (27.8%)Phase 2
10 (18.5%)Phase 3
6 (11.1%)Phase 4
1 (1.9%)Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns
Phase 3
Not yet recruiting
- Conditions
- Severe Diabetic Macular Oedema
- Interventions
- Procedure: Subthreshold Micropulse Laser (SML)Drug: Anti-VEGF Monotherapy (standard care)
- First Posted Date
- 2025-05-22
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Belfast Health and Social Care Trust
- Target Recruit Count
- 264
- Registration Number
- NCT06985706
- Locations
- 🇬🇧
The Royal Hospitals Belfast, Belfast, United Kingdom
🇬🇧Birmingham and Midland Eye Centre, Birmingham, United Kingdom
🇬🇧Sussex Eye Hospital, Brighton, United Kingdom
Can the Use of Virtual Reality Improve TKA Outcomes
Not Applicable
Recruiting
- Conditions
- Total Knee Arthroplasty
- First Posted Date
- 2025-05-08
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Belfast Health and Social Care Trust
- Target Recruit Count
- 40
- Registration Number
- NCT06962046
- Locations
- 🇬🇧
Musgrave Park Hospital, Belfast, United Kingdom
Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis
Phase 1
Not yet recruiting
- Conditions
- SepsisFluid OverloadEndothelial DysfunctionMicrocirculation
- Interventions
- Drug: Compound sodium lactate solution
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Belfast Health and Social Care Trust
- Target Recruit Count
- 65
- Registration Number
- NCT06626984
The Use of ARA290 for the Treatment of Diabetic Macular Oedema
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Belfast Health and Social Care Trust
- Target Recruit Count
- 9
- Registration Number
- NCT06626971
- Locations
- 🇬🇧
Belfast Health & Social Care Trust, Belfast, Co Antrim, United Kingdom
IMProving Outcomes With ACT After Knee Surgery
Not Applicable
Not yet recruiting
- Conditions
- Total Knee ArthroplastyKnee Osteoarthritis
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Belfast Health and Social Care Trust
- Target Recruit Count
- 50
- Registration Number
- NCT06483191
- Locations
- 🇬🇧
Musgrave Park Hospital, Belfast, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
No news found